肺肝素与黏液肝素的抗凝活性 - Suppr

Suppr

超能文献

Anticoagulant activities of lung and mucous heparins.

作者信息

Barrowcliffe T W, Johnson E A, Eggleton C A, Thomas D P

出版信息

Thromb Res. 1978 Jan;12(1):27-36. doi: 10.1016/0049-3848(78)90082-8.

DOI:10.1016/0049-3848(78)90082-8

PMID:644557

Abstract

摘要

相似文献

Anticoagulant activities of lung and mucous heparins.

Thromb Res. 1978 Jan;12(1):27-36. doi: 10.1016/0049-3848(78)90082-8.

The heterogeneity of heparins.

Fed Proc. 1977 Jan;36(1):92-7.

Anticoagulant activity of two commercially available heparin preparations. A controlled study.

J Clin Pharmacol New Drugs. 1972 Oct;12(10):413-6. doi: 10.1002/j.1552-4604.1972.tb00142.x.

Anticoagulant activity of whale intestine heparin and its clinical application.

Bibl Haematol. 1968;29:1141-9. doi: 10.1159/000384753.

A low molecular weight heparin compared with unfractionated heparin.

Thromb Res. 1982 Nov 1;28(3):343-50. doi: 10.1016/0049-3848(82)90116-5.

In vitro comparative study of the anticoagulant action of lung and gut heparin: part 1.

Osaka City Med J. 1980;26(1):19-37.

Comparison of anticoagulant activity of two preparations of purified heparin.

Clin Pharmacol Ther. 1973 Mar-Apr;14(2):287-90. doi: 10.1002/cpt1973142287.

Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.

Thromb Haemost. 2012 May;107(5):903-15. doi: 10.1160/TH-11-07-0518. Epub 2012 Mar 22.

Anticoagulant activity of heparin: assay of bovine, human and porcine preparations by amidolytic and clotting methods.

Thromb Res. 1977 Aug;11(2):107-17. doi: 10.1016/0049-3848(77)90029-9.

[Characteristics of heparin. II. Chromatographic behavior and biologic activity].

Farmaco Prat. 1970 Feb;25(2):130-41.

引用本文的文献

Structural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugs.

Sci Rep. 2016 Oct 18;6:35619. doi: 10.1038/srep35619.

An evaluation of the British Pharmacopoeial assay of heparin: a comparison with other methods.

J Clin Pathol. 1980 Jun;33(6):562-5. doi: 10.1136/jcp.33.6.562.

Clinical pharmacokinetics of heparin.

Clin Pharmacokinet. 1980 May-Jun;5(3):204-20. doi: 10.2165/00003088-198005030-00002.

Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis.

Br Med J (Clin Res Ed). 1982 Feb 6;284(6313):375-9. doi: 10.1136/bmj.284.6313.375.

[Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].

Klin Wochenschr. 1986 Nov 17;64(22):1171-5. doi: 10.1007/BF01728455.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Anticoagulant activities of lung and mucous heparins.

作者信息

Barrowcliffe T W, Johnson E A, Eggleton C A, Thomas D P

出版信息

Thromb Res. 1978 Jan;12(1):27-36. doi: 10.1016/0049-3848(78)90082-8.

DOI:10.1016/0049-3848(78)90082-8

PMID:644557

Abstract

摘要

相似文献

Anticoagulant activities of lung and mucous heparins.

Thromb Res. 1978 Jan;12(1):27-36. doi: 10.1016/0049-3848(78)90082-8.

The heterogeneity of heparins.

Fed Proc. 1977 Jan;36(1):92-7.

Anticoagulant activity of two commercially available heparin preparations. A controlled study.

J Clin Pharmacol New Drugs. 1972 Oct;12(10):413-6. doi: 10.1002/j.1552-4604.1972.tb00142.x.

Anticoagulant activity of whale intestine heparin and its clinical application.

Bibl Haematol. 1968;29:1141-9. doi: 10.1159/000384753.

A low molecular weight heparin compared with unfractionated heparin.

Thromb Res. 1982 Nov 1;28(3):343-50. doi: 10.1016/0049-3848(82)90116-5.

In vitro comparative study of the anticoagulant action of lung and gut heparin: part 1.

Osaka City Med J. 1980;26(1):19-37.

Comparison of anticoagulant activity of two preparations of purified heparin.

Clin Pharmacol Ther. 1973 Mar-Apr;14(2):287-90. doi: 10.1002/cpt1973142287.

Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.

Thromb Haemost. 2012 May;107(5):903-15. doi: 10.1160/TH-11-07-0518. Epub 2012 Mar 22.

Anticoagulant activity of heparin: assay of bovine, human and porcine preparations by amidolytic and clotting methods.

Thromb Res. 1977 Aug;11(2):107-17. doi: 10.1016/0049-3848(77)90029-9.

[Characteristics of heparin. II. Chromatographic behavior and biologic activity].

Farmaco Prat. 1970 Feb;25(2):130-41.

引用本文的文献

Structural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugs.

Sci Rep. 2016 Oct 18;6:35619. doi: 10.1038/srep35619.

An evaluation of the British Pharmacopoeial assay of heparin: a comparison with other methods.

J Clin Pathol. 1980 Jun;33(6):562-5. doi: 10.1136/jcp.33.6.562.

Clinical pharmacokinetics of heparin.

Clin Pharmacokinet. 1980 May-Jun;5(3):204-20. doi: 10.2165/00003088-198005030-00002.

Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis.

Br Med J (Clin Res Ed). 1982 Feb 6;284(6313):375-9. doi: 10.1136/bmj.284.6313.375.

[Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].

Klin Wochenschr. 1986 Nov 17;64(22):1171-5. doi: 10.1007/BF01728455.